TANGO THERAPEUTICS INC (TNGX) Stock Balance Sheet
NASDAQ:TNGX - Nasdaq - US87583X1090 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | 1.30M | |||
| Cash Equivalents | 53.15M | 66.39M | 60.00M | 142.70M | N/A | |||
| Marketable Securities | 240.13M | 270.50M | 306.20M | 342.50M | N/A | |||
| Receivables | N/A | 0.00 | 2.00M | 2.00M | N/A | |||
| Other Current Assets | 7.54M | 9.65M | 7.20M | 5.10M | 200.00K | |||
| Total Current Assets | 300.81M | 346.54M | 375.30M | 492.30M | 1.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 49.02M | 53.42M | 57.80M | 6.10M | N/A | |||
| Investments And Advances | N/A | N/A | N/A | N/A | 166.80M | |||
| Other Non-Current Assets | 2.58M | 2.61M | 3.40M | 1.70M | N/A | |||
| Total Non-Current Assets | 51.60M | 56.03M | 61.20M | 7.90M | 166.80M | |||
| TOTAL ASSETS | 352.42M | 402.57M | 436.50M | 500.20M | 168.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 17.87M | 17.48M | 19.30M | 11.40M | 100.00K | |||
| Accounts Payable | 4.11M | 2.79M | 4.50M | 3.20M | N/A | |||
| Other Current Liabilities | 15.60M | 25.67M | 31.80M | 26.10M | 0.00 | |||
| Total Current Liabilities | 37.58M | 45.94M | 55.50M | 40.70M | 100.00K | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 85.66M | 103.52M | 131.40M | 114.70M | 5.80M | |||
| Total Non-Current Liabilities | 85.66M | 103.52M | 131.50M | 114.70M | 5.90M | |||
| TOTAL LIABILITIES | 123.25M | 149.46M | 187.00M | 155.40M | 6.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -463.89M | -371.26M | -269.50M | -161.30M | -100.00K | |||
| Additional Paid In Capital | 692.20M | 624.08M | 522.60M | 506.80M | 5.10M | |||
| Common Shares | 107.00K | 102.00K | 100.00K | 100.00K | 157.40M | |||
| Other Shareholders' Equity | 750.00K | 186.00K | -3.70M | -800.00K | N/A | |||
| Shares Outstanding | 107.41M | 102.20M | 88.20M | 87.70M | 21.40M | |||
| Tangible Book Value per Share | 2.13 | 2.48 | 2.83 | 3.93 | 7.59 | |||
| Total Shareholders' Equity | 229.17M | 253.11M | 249.50M | 344.70M | 162.40M | |||
| TOTAL LIABILITIES AND EQUITY | 352.42M | 402.57M | 436.50M | 500.20M | 168.30M | |||
| Statistics | ||||||||
| Current Ratio | 8.00 | 7.54 | 6.76 | 12.10 | 15.00 | |||
| Return On Assets (ROA) | -35.01% | -25.27% | -24.78% | -11.64% | -0.07% | |||
| Return On Equity (ROE) | -53.84% | -40.20% | -43.36% | -16.90% | -0.07% | |||
All data in USD , ROIC based on taxRate of 0.21